Application no. and date | 18150455.6 (espacenet) (Federated) (European Patent Register), 20180105 | Patent/reg. no. and date | DK/EP 3446705, 20210922 | Publication date | 20190227 | Priority no. and date | EP 17187684, 20170824 | EP pub. no. and date |
EP 3446705 20190227 | Effective date | | Applicant/owner | Isofol Medical AB, Biotech Center Arvid Wallgrens Backe 20
413 46 Gothenburg, SE | Applicant ref. no. | 165141 | Inventor | Gustavsson, Bengt, Bergsbogatan 29
426 79 Västra Frölunda, SE, LINDBERG, Per Lennart, Mellangatan 7
41301 Göteborg, SE, VEDIN, Anders, Prästgårdsgatan 62 412 71 Göteborg, SE, SUNDÉN, Gunnel Elisabet, Mellangatan 7
413 01 Göteborg, SE | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | Opponent | | IPC Class | A61K 31/4745 (2006.01) , A61K 31/513 (2006.01) , A61K 31/519 (2006.01) , A61K 39/00 (2006.01) , A61P 35/00 (2006.01) | Title | [6R]-MTHF ET EFFEKTIVT FOLAT-ALTERNATIV I 5-FLUORURACILBASERET KEMOTERAPI | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|